Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology…
Lyra Health Joins Workday Wellness Program as Preferred Mental Health Partner Lyra Health, the leader in workforce mental health solutions, announced that it has been named the Workday Wellness Preferred Mental Health Partner. This designation recognizes Lyra’s extensive experience in…
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C GeneDx the leader in rare disease diagnosis and improving health through the power of genomic data, announced a new genetic testing program…
IFF Expands Production and Innovation Capabilities in Latin America with New Enzyme Hub and Applications Laboratory Global ingredients and biosciences leader IFF is strengthening its footprint in Latin America through a strategic expansion designed to boost production capacity, innovation, and…
Taiwan Excellence Pavilion Debuts at HIMSS 2026 with Practical AI, Digital Healthcare Platforms, and Medical-Grade Computing Taiwanese healthcare technology innovators made a strong impression at the HIMSS 2026, introducing deployment-ready artificial intelligence solutions, digital care platforms, and medical-grade computing systems…
National Kidney Foundation to Honor Dallas Nephrology Associates with 2026 Award Dallas Nephrology Associates (DNA) has been selected to receive the prestigious Burl Osborne Award at the 2026 Bonne Santé event hosted by the National Kidney Foundation (NKF). The recognition…
TIXiMED Reports Promising Preclinical Results for Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED a clinical-stage pharmaceutical company focused on developing innovative treatments for diabetes and metabolic diseases, has announced encouraging new preclinical findings for its investigational oral…
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice…
First Patient Dosed in Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for ecopipam, an investigational first-in-class D1 receptor antagonist in development for…
Innovaccer Launches Flow Capture, Bringing Autonomous Coding to the Frontlines of American Healthcare Innovaccer, the leading healthcare AI company, launched Flow Capture, an autonomous medical coding solution designed to eliminate one of the most persistent bottlenecks in American healthcare: manual…
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026 SpotitEarly, a multi-cancer early detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, today announced that Fierce Healthcare has named it as one…
New Real-World Evidence Study Shows Leva® Pelvic Health System Significantly Improves Fecal Incontinence Symptoms in Women Axena Health, Inc., a women’s health company redefining the standard of care for pelvic health through clinically proven, non-invasive treatments, today announced the publication of a…